β-Tryptase up-regulates vascular endothelial growth factor expression via proteinase-activated receptor-2 and mitogen-activated protein kinase pathways in bone marrow stromal cells in acute myeloid leukemia

Leukemia and Lymphoma

Volumn 51, Issue 8, 2010, Pages 1550-1558

  Yang, Xiu Peng ^a   Li, Yan ^a   Wang, Yazhu ^a   Wang, Yue ^a   Wang, Pingping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

tryptase; AM L; ERK1 2; P38MAPK; PAR 2; VEGF

Indexed keywords

BETA TRYPTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 2; TRYPTASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, PAR-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STROMAL CELLS; TRYPTASES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955443521     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.496013     Document Type: Article

References (41)

1. Sperr WR, Jordan JH, Baghestanian M, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001;98:2200-2209.
2. Sonneck K, Florian S, Böhm A, et al. Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemia. Leuk Lymphoma 2006;47:897-906.
3. Sommerhoff CP, Bode W, Matschiner G, Bergner A, Fritz H. The human mast cell tryptase tetramer: a fascinating riddle solved by structure, Biochim Biophys Acta 2000;1477:75-89.
4. Abe M, Kurosawa M, Ishikawa O, Miyachi Y, Kido H. Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin Exp Allergy 1998;28:1509-1517.
5. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol 2002;169:2662-2669.
6. Mullan CS, Riley M, Clarke D, et al. Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2- independent mechanism. Am J Respir Cell Mol Biol 2008;38:600-608.
7. Tatler AL, Porte J, Knox A, Jenkins G, Pang L. Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis. Biochem Biophys Res Commun 2008;370:239-242.
8. Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997;99:2691-2700.
9. Boudreau N, Myers C. Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Res 2003;5:140-146.
10. Kharfan-Dabaja MA, Patel SA, Osunkoya AO, et al. Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining. Clin Lab Haematol 2006;28:254-258.
11. ValesA,Kondo R, Aichberger KJ, et al. Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. Leuk Lymphoma 2007;48:1997-2007.
12. Li Yan, Zhang R, Lu XL, et al. Tryptase relation to VEGF in acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005;13:793-797.
13. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 1976;33:451-458.
14. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.Ann Intern Med 1985;103:620-625.
15. Vogel W, Grünebach F, Messam CA, et al. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003;88:126-133.
16. Livak KL, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 27DDCT method. Methods 2001;25:402-408.
17. Ranieri G, AmmendolaM, Patruno R, et al. Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol 2009;35:115-120.
18. Ribatti D, Finato N, Crivellato E, et al. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathology 2007;51:837- 842.
19. Ibaraki T, Muramatsu M, Takai S, et al. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005;28:617-621.
20. Ibaraki T, Muramatsu M, Takai S, et al. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005;28:617-621.
21. Garvin S, Dabrosin C. In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients. BMC Cancer 2008;8:1-6.
22. Zlobec I, Vuong T, Compton CC, et al. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer 2008;98:450-456.
23. Zhang K, Hu S, Wu J, et al. Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis. Mol Cancer 2009;28:8-11.
24. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240-2245.
25. Keith T, Araki Y, Ohyagi M, et al. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. Br J Haematol 2007;137:206-215.
26. Hiramatsu A, Miwa H, Shikami M, et al. Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML. Leuk Lymphoma 2006;47:89-95.
27. Imai N, Shikami M, Miwa H, et al. t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type 2 pathway and phosphorylation of Akt. Br J Haematol 2006;135:673-682.
28. Kessler T, Fehrmann F, Bieker R, Berdel WE. Mesters RM. Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies. Curr Drug Targets 2007;8:257-268.
29. Kawabata A, Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J Pharmacol 2000;82:171-174.
30. Déry O, Corvera CU, Steinhoff M, Bunnett NW. Proteinaseactivated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998;274:C1429-C1452.
31. Gruber BL, Marchese MJ, Santiago-Schwarz F, et al. Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix. J Invest Dermatol 2004;123:832-839.
32. Ritchie E, Saka M, MacKenzie C, et al. Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase b in human endothelial cells. Br J Pharmacol 2007;150:1044- 1054.
33. Freund-Michel V, Frossard N. Inflammatory conditions increase expression of protease-activated receptor-2 by human airway smooth muscle cells in culture. Fundam Clin Pharmacol 2006;20:351-357.
34. Nickel TJ, Kabir MH, Talreja J, Stechschulte DJ, Dileepan KN. Constitutive expression of functionally active proteaseactivated receptors 1 and 2 in human conjunctival epithelial cells. Mediators Inflamm 2006;2006:1-8.
35. Li T, He S. Induction of IL-6 release from human T cells by PAR-1 and PAR-2 agonists. Immunol Cell Biol 2006;84:461- 466.
36. Kajikawa H, Yoshida N, Katada K, et al. Helicobacter pylori activates gastric epithelial cells to produce interleukin- 8 via protease-activated receptor 2. Digestion 2008;76:248- 255.
37. Chiu LL, Perng DW, Yu CH, Su SN, Chow LP. Mold allergen, pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2. J Immunol 2007;178:5237-5244.
38. Liu Y, Mueller BM. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB- 231 cells via MAPK pathways. Biochem Biophys Res Commun 2006;344:1263-1270.
39. Syeda F, Grosjean J, Houliston RA, et al. Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. J Biol Chem 2006;281:11792-11804.
40. Boileau C, Amiable N, Martel-Pelletier J, et al. Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study. Arthritis Res Ther 2007;9:R121.
41. Pan SL, Tao KY, Guh JH, et al. The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion. Shock 2008;305:496-502.